ERIN CROWN: Open Payments
NPI 1831535780 · STATE COLLEGE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$362,228 in 582 payments from 17 companies in 2025. Trend: 2023 $361,220 · 2024 $294,130 · 2025 $362,228
Speaker / faculty: $153,956Honoraria: $90,141Travel & lodging: $62,587Consulting: $44,916Food & beverage: $10,629
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 155 | $120,842 |
| Axsome Therapeutics, Inc. | 142 | $104,007 |
| E.R. Squibb & Sons, L.L.C. | 59 | $49,200 |
| Otsuka America Pharmaceutical, Inc. | 81 | $37,944 |
| Neurocrine BioSciences, Inc. | 33 | $20,333 |
| Janssen Pharmaceuticals, Inc | 28 | $17,155 |
| Supernus Pharmaceuticals, Inc. | 29 | $9,311 |
| ABBVIE INC. | 19 | $1,557 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $1,060 |
| Lundbeck LLC | 7 | $246 |
Products named: CAPLYTA, Auvelity, COBENFY, ABILIFY MAINTENA, INGREZZA, SPRAVATO, REXULTI, Qelbree.
Industry payments across PA — which companies pay providers there.
